CJC-1295 Ipamorelin blend

CJC-1295 and Ipamorelin are synthetic peptides commonly utilized in research settings to study mechanisms involved in growth hormone (GH) signaling and pituitary secretory pathways.

CJC-1295 is a growth hormone–releasing hormone (GHRH) analog investigated for its interaction with the GHRH receptor, while Ipamorelin is a selective growth hormone secretagogue studied for its activity at the ghrelin (GHS-R) receptor. When combined, this peptide blend is frequently examined in laboratory models for its potential role in modulating endogenous GH release patterns.

Each vial is manufactured to meet high purity standards and is intended strictly for qualified research applications.

For research use only. Not for human or veterinary use.